Immuno-logical enhancement system by genetic vaccines.

A method is invented for enhancing humoral immune response of DNA vaccine by incorporating a viral nucleoprotein (NP) gene as part of the vaccine. The NP gene joins with a target protein gene and encodes an antigenic protein for which specific antibodies shall be produced. The 6xHis DNA sequence (AT...

Full description

Bibliographic Details
Main Authors: Mohd. Lila, Mohd. Azmi, Lai, Kit Yee
Format: Patent
Published: 2002
Online Access:http://psasir.upm.edu.my/id/eprint/25831/
_version_ 1848845412474028032
author Mohd. Lila, Mohd. Azmi
Lai, Kit Yee
author_facet Mohd. Lila, Mohd. Azmi
Lai, Kit Yee
author_sort Mohd. Lila, Mohd. Azmi
building UPM Institutional Repository
collection Online Access
description A method is invented for enhancing humoral immune response of DNA vaccine by incorporating a viral nucleoprotein (NP) gene as part of the vaccine. The NP gene joins with a target protein gene and encodes an antigenic protein for which specific antibodies shall be produced. The 6xHis DNA sequence (ATC ATC ATC ATC ATC ATC) that encodes the 6xHis protein (also known as His protein) is incorporated either in front of the DNA sequence that encodes the NP, or between the NP and the target protein genes, or at the end of the DNA sequence that encode the target protein. To enable the insertion of any target protein gene, a multiple cloning site (MCS) is placed at the location immediately after the DNA sequence that encodes NP. The recombinant plasmid (or genetic vaccine) shall be purified and adminstered into the hos by injection or any other means. The vaccination will facilitate in vivo expression of NP-terget protein to induce or enhance antibody response against target protein concurrently with cell-mediated immune response.
first_indexed 2025-11-15T08:46:24Z
format Patent
id upm-25831
institution Universiti Putra Malaysia
institution_category Local University
last_indexed 2025-11-15T08:46:24Z
publishDate 2002
recordtype eprints
repository_type Digital Repository
spelling upm-258312013-10-28T05:55:22Z http://psasir.upm.edu.my/id/eprint/25831/ Immuno-logical enhancement system by genetic vaccines. Mohd. Lila, Mohd. Azmi Lai, Kit Yee A method is invented for enhancing humoral immune response of DNA vaccine by incorporating a viral nucleoprotein (NP) gene as part of the vaccine. The NP gene joins with a target protein gene and encodes an antigenic protein for which specific antibodies shall be produced. The 6xHis DNA sequence (ATC ATC ATC ATC ATC ATC) that encodes the 6xHis protein (also known as His protein) is incorporated either in front of the DNA sequence that encodes the NP, or between the NP and the target protein genes, or at the end of the DNA sequence that encode the target protein. To enable the insertion of any target protein gene, a multiple cloning site (MCS) is placed at the location immediately after the DNA sequence that encodes NP. The recombinant plasmid (or genetic vaccine) shall be purified and adminstered into the hos by injection or any other means. The vaccination will facilitate in vivo expression of NP-terget protein to induce or enhance antibody response against target protein concurrently with cell-mediated immune response. 2002-09-09 Patent NonPeerReviewed Mohd. Azmi Mohd. Lila (2002) Immuno-logical enhancement system by genetic vaccines. UNSPECIFIED.
spellingShingle Mohd. Lila, Mohd. Azmi
Lai, Kit Yee
Immuno-logical enhancement system by genetic vaccines.
title Immuno-logical enhancement system by genetic vaccines.
title_full Immuno-logical enhancement system by genetic vaccines.
title_fullStr Immuno-logical enhancement system by genetic vaccines.
title_full_unstemmed Immuno-logical enhancement system by genetic vaccines.
title_short Immuno-logical enhancement system by genetic vaccines.
title_sort immuno-logical enhancement system by genetic vaccines.
url http://psasir.upm.edu.my/id/eprint/25831/